Business · 05/08/2021
FDA Issues Emergency Use Authorizations for COVID-19 Biological Products
The US Food and Drug Administration (FDA) has granted two Emergency Use Authorizations (EUAs) for biological products to treat COVID-19, following a public health emergency declaration by the Secretary of Health and Human Services in March 2020.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →